Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in HCV/HIV Co-infection
NCT00983853Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Oct 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of telaprevir in hepatitis C (HCV), sponsored by Vertex Pharmaceuticals. Started Oct 2009; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00983853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983853.